Analysis reveals that inhibiting fibulin-3 reduces immunosuppressive signaling, suggesting enhanced macrophage activity in glioblastoma.
Figure S2. Analysis of TAMs in intracranial tumors by quantitative immunohistochemistry.
No takes yet. Share an insight, caveat, or question.
Kundu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: